Notice of Preliminary Results

RNS Number : 2372T

Genedrive PLC

11 October 2017

 

RNS  

For release: 11 October 2017

genedrive plc ("genedrive" or the "Company")

Notice of Preliminary Results

genedrive plc (LSE: GDR), the molecular diagnostics company, will be announcing its preliminary results for the twelve months ending 30 June 2017 on Tuesday 17 October, 2017.

David Budd, Chief Executive Officer, and Matthew Fowler, Chief Financial Officer, will host a presentation and simultaneous live conference call for analysts, followed by a Q&A session, at 11:00am on the day of the results. The presentation will be held at 85 Gresham Street, London, EC2R 7HE.

- Ends -

For further details please contact:

genedrive plc

David Budd: CEO                                                                                                              [phone]

Matthew Fowler: Finance Director

Peel Hunt LLP

James Steel                                                                                                                      [phone]

Oliver Jackson

Consilium Strategic Communications

Chris Gardner                                                                                                                   [phone]

Matthew Neal

Laura Thornton

[e-mail] 

Notes to Editors

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. Further details can be found at: www.genedriveplc.com and www.genedrive.com.

 

END

 

 

NOROKKDNPBDDFKD